Special Issue

Topic: Resistance to Cancer Immunotherapy: Mechanisms, Advances, Challenges and Opportunities

A Special Issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 30 Apr 2023

Guest Editor(s)

Dr. Michael Lahn

iOnctura SA, Geneva, Switzerland.

Dr. Jordi Rodon
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Prof. Hendrik Tobias Arkenau

Drug Development Unit, Sarah Cannon Research Institute, London, UK.

Special Issue Introduction

Despite the clinical benefit obtained with current cancer immunotherapy, there is a large group of patients who do not respond or respond poorly to current therapies. In fact, some even show hyperprogression once immunotherapy is started. Underlying mechanisms of resistance are thought to be driving this lack of response to immunotherapy.
In the present Special Issue, the various concepts of resistance mechanisms will be summarized. This will include mechanisms of primary resistance, various barriers to immunotherapies, the selection of tumour clones that lead to resistance and finally the molecular changes within tumour cells rendering them resistant to therapy.
An important pillar for studying resistance is the available tools to detect and monitor resistance in patients. Biomarker tests that can assess emerging or pre-existing intrinsic or extrinsic factors leading to resistance are perhaps more than ever needed to direct physicians towards seeking novel therapies.
This Special Issue aims to compile a collection of updated research, review and expert opinion articles on resistance mechanisms, the available strategies to detect such developments and propose potential novel therapeutic approaches.
Concept of resistance to immunotherapy
Potential mechanisms of resistance to immunotherapy
Targets for overcoming resistance to immunotherapy

Special Issue e-book download link: https://oaepublishstorage.blob.core.windows.net/uploadedfiles/CDR-Special-Issue---Resistance-to-Cancer-Immunotherapy.pdf


Immunotherapy resistance, potential mechanisms of immunotherapy resistance, targets for overcoming immunotherapy resistance, immune checkpoints inhibitors

Submission Deadline

30 Apr 2023

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/cdr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=CDR221026
Submission Deadline: 30 Apr 2023
Contacts: Belinda Zhang, Assistant Editor, Belinda@cdrjournal.com

Published Articles

Targeting T regulatory (Treg) cells in immunotherapy-resistant cancers
Open Access Review 11 Jan 2024
Views: Downloads:
Download PDF
Unlocking antitumor immunity with adenosine receptor blockers
Open Access Review 24 Oct 2023
Views: Downloads:
Download PDF
Drug resistance in glioblastoma: from chemo- to immunotherapy
Open Access Review 10 Oct 2023
Views: Downloads:
Download PDF
Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia
Open Access Review 25 Sep 2023
Views: Downloads:
Download PDF
Cancer Drug Resistance
ISSN 2578-532X (Online)


All published articles will preserved here permanently:



All published articles will preserved here permanently: